Latest Governance News

Arafura Rare Earths launches a two-tranche A$350 million placement and a A$25 million share purchase plan, closing the equity funding gap for its Nolans Rare Earths Project ahead of construction.

Maronan Metals has completed a major share distribution from Red Metal, expanding its shareholder base, while locking in a $22 million strategic investment to fund an ambitious drilling program and feasibility study.

HIQ Limited has locked in non-dilutive funding from the Victorian Government to underpin a $4.9 million project expanding its manufacturing and research footprint in Victoria, supporting its global growth ambitions.

Tivan Limited has formalised binding joint venture agreements with Timor-Leste’s state-owned Murak Rai Timor to develop the Baucau and Ossu copper-gold projects, targeting maiden drilling at Ossu in late 2026.

White Cliff Minerals has landed a CAD$250,000 exploration grant from Nunavut’s government to fund a 6,000m drilling campaign at the Danvers deposit, reinforcing the Rae Copper Project’s potential in a Tier-1 mining jurisdiction.

Ragusa Minerals has started an induced polarisation geophysical survey at the Black Rock Manganese Mine within its Purple Pansy Project in Arizona, aiming to map high-grade manganese mineralisation and prepare for drilling.

Oceania Healthcare Limited has delivered a standout FY26 with 16% higher sales, 20% EBITDA growth, and a 19% reduction in net debt, setting the stage for positive cash flow in FY27 despite no dividend declared this year.

Right Resources has identified a significant high-grade tungsten system at its Blue Prospect in NSW, with rock chip assays reaching 4.3% WO3 and a large soil anomaly still open in all directions.

Bougainville Copper has secured AUD 6.5 million through a share placement to institutional and sophisticated investors, aiming to fund exploration and bolster working capital.

Avecho Biotechnology has wrapped up the treatment phase for its pivotal Phase III insomnia trial involving 244 participants, setting the stage for an interim efficacy analysis expected in late June 2026.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Energy One Limited reveals solid sales momentum and strategic AI integration under new CEO Ben Tranier, despite slight ARR timing delays and ongoing market complexity.